Search Browse Earnings

MACROGENICS INC

Nasdaq:MGNX

Pharmaceutical Preparations·Rockville, MD

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CEO

Risser Eric Blasius

CFO

Karrels James

Revenue

$58.7M

-61.3% YoY

FY 2025

Adj. EBITDA

-$158.6M

-270.0% margin

FY 2025

Net Income

-$9.1M

-15.4% margin

FY 2025

EPS (Diluted)

-$0.15

FY 2025

Stock Price

$3.43

+53.8%

2026-03-10

52W Range

$0.99 – $2.48

P/E Ratio

-22.9x

Market Cap

$218.0M

Cash

$182.8M

FY 2025

Total Debt

—

Net Cash

$182.8M

FY 2025

Enterprise Value

$35.2M

Debt / EBITDA

1.2x

FY 2025

EV / EBITDA

-0.2x

Employees

—